Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 470,208 shares of the pharmacy operator’s stock after selling 18,532 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Walgreens Boots Alliance were worth $18,752,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Johnson Midwest Financial LLC purchased a new position in Walgreens Boots Alliance during the fourth quarter worth approximately $26,000. McIlrath & Eck LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth approximately $29,000. McCarthy Asset Management Inc. purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at approximately $32,000. Hexagon Capital Partners LLC grew its stake in Walgreens Boots Alliance by 6,641.7% in the 4th quarter. Hexagon Capital Partners LLC now owns 809 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 797 shares during the period. Finally, Syverson Strege & Co purchased a new stake in Walgreens Boots Alliance in the 4th quarter worth $35,000. 55.96% of the stock is owned by institutional investors.

Shares of Walgreens Boots Alliance stock opened at $48.86 on Tuesday. Walgreens Boots Alliance, Inc. has a 52 week low of $33.36 and a 52 week high of $55.49. The business’s fifty day simple moving average is $48.43 and its 200-day simple moving average is $41.00. The firm has a market cap of $42.22 billion, a PE ratio of 97.72, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 0.58.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, January 6th. The pharmacy operator reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.19. The firm had revenue of $36.31 billion for the quarter, compared to analyst estimates of $35.01 billion. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. Walgreens Boots Alliance’s revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.37 EPS. As a group, equities analysts expect that Walgreens Boots Alliance, Inc. will post 4.84 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 12th. Stockholders of record on Friday, February 19th will be issued a $0.4675 dividend. The ex-dividend date of this dividend is Thursday, February 18th. This represents a $1.87 annualized dividend and a dividend yield of 3.83%. Walgreens Boots Alliance’s dividend payout ratio is currently 39.45%.

WBA has been the topic of several research analyst reports. Truist lifted their target price on shares of Walgreens Boots Alliance from $44.00 to $48.00 in a research report on Friday, January 8th. Mizuho increased their price objective on Walgreens Boots Alliance from $37.00 to $47.00 and gave the company a “neutral” rating in a research note on Monday, January 11th. Robert W. Baird raised shares of Walgreens Boots Alliance from a “neutral” rating to an “outperform” rating and lifted their target price for the stock from $41.00 to $55.00 in a research note on Monday, January 11th. TheStreet lowered shares of Walgreens Boots Alliance from a “b-” rating to a “c” rating in a report on Thursday, January 7th. Finally, Guggenheim raised shares of Walgreens Boots Alliance from a “neutral” rating to a “buy” rating and set a $55.00 price target on the stock in a research note on Monday, January 11th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $44.50.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Recommended Story: How a Strangle Strategy is different from a Straddle Strategy

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.